9458 related articles for article (PubMed ID: 19178659)
21. Recent approaches to the treatment of neoplastic disease in animals.
Cardeilhac PT
J Am Vet Med Assoc; 1970 Feb; 156(3):355-64. PubMed ID: 5467063
[No Abstract] [Full Text] [Related]
22. Amifostine protects against cisplatin-induced nephrotoxicity in a child with medulloblastoma.
Hayek M; Srinivasan A
Pediatr Hematol Oncol; 2003; 20(3):253-6. PubMed ID: 12637222
[No Abstract] [Full Text] [Related]
23. How to keep kidneys safe while shrinking tumors: the conundrum of cisplatin action.
Goligorsky MS
Am J Physiol Renal Physiol; 2007 Jul; 293(1):F50-1. PubMed ID: 17507601
[No Abstract] [Full Text] [Related]
24. Evaluation of cisplatin combined with piroxicam for the treatment of oral malignant melanoma and oral squamous cell carcinoma in dogs.
Boria PA; Murry DJ; Bennett PF; Glickman NW; Snyder PW; Merkel BL; Schlittler DL; Mutsaers AJ; Thomas RM; Knapp DW
J Am Vet Med Assoc; 2004 Feb; 224(3):388-94. PubMed ID: 14765798
[TBL] [Abstract][Full Text] [Related]
25. Sodium-wasting nephropathy caused by cisplatin in esophageal cancer.
Abdelghani L; Modha K; Albaddawi E; Subramanian S
J Support Oncol; 2008; 6(7):305-6. PubMed ID: 18847072
[No Abstract] [Full Text] [Related]
26. Platinum complexes in cancer chemotherapy.
Antibiot Chemother (1971); 1978; 23():99-112. PubMed ID: 348089
[TBL] [Abstract][Full Text] [Related]
27. Reducing toxicity of cisplatin in cancer chemotherapy by extracorporeal removal of excess cisplatin.
Ambruss CM; Karakousis CP; Stadler A; Stadler I; Ambrus JL; Anthone S; Ambrus JL
J Med; 2002; 33(1-4):119-27. PubMed ID: 12939112
[TBL] [Abstract][Full Text] [Related]
28. Methods of reduction of cisplatin nephrotoxicity.
Walker EM; Gale GR
Ann Clin Lab Sci; 1981; 11(5):397-410. PubMed ID: 6277229
[TBL] [Abstract][Full Text] [Related]
29. The present status of BCG treatment in the veterinary practice.
Klein WR; Rutten VP; Steerenberg PA; Ruitenberg EJ
In Vivo; 1991; 5(6):605-8. PubMed ID: 1810446
[TBL] [Abstract][Full Text] [Related]
30. Modern methods for diagnosis and monitoring of nephrotoxicity during antitumor therapy with platinum derivatives.
Lyubimova NV; Topchieva SV; Averinova SG; Kashkadaeva AV; Gorbunova VA; Shiryaev SV; Kushlinskii NE
Bull Exp Biol Med; 2000 Sep; 130(9):886-91. PubMed ID: 11177273
[TBL] [Abstract][Full Text] [Related]
31. Advances in Toxicological Research of the Anticancer Drug Cisplatin.
Qi L; Luo Q; Zhang Y; Jia F; Zhao Y; Wang F
Chem Res Toxicol; 2019 Aug; 32(8):1469-1486. PubMed ID: 31353895
[TBL] [Abstract][Full Text] [Related]
32. The ability of mannitol to decrease cisplatin-induced nephrotoxicity in children: real or not?
Ruggiero A; Rizzo D; Trombatore G; Maurizi P; Riccardi R
Cancer Chemother Pharmacol; 2016 Jan; 77(1):19-26. PubMed ID: 26589789
[TBL] [Abstract][Full Text] [Related]
33. [Nephropathy in Patients Undergoing Cancer Drug Therapy - Platinum Derivatives(Cisplatin and Carboplatin)].
Matsuoka A; Ando Y
Gan To Kagaku Ryoho; 2017 Mar; 44(3):200-203. PubMed ID: 28292990
[TBL] [Abstract][Full Text] [Related]
34. 5-Azacytidine prevents cisplatin induced nephrotoxicity and potentiates anticancer activity of cisplatin by involving inhibition of metallothionein, pAKT and DNMT1 expression in chemical induced cancer rats.
Tikoo K; Ali IY; Gupta J; Gupta C
Toxicol Lett; 2009 Dec; 191(2-3):158-66. PubMed ID: 19723570
[TBL] [Abstract][Full Text] [Related]
35. An integrated view of cisplatin-induced nephrotoxicity and ototoxicity.
Karasawa T; Steyger PS
Toxicol Lett; 2015 Sep; 237(3):219-27. PubMed ID: 26101797
[TBL] [Abstract][Full Text] [Related]
36. Megalin genetic polymorphisms and individual sensitivity to the ototoxic effect of cisplatin.
Riedemann L; Lanvers C; Deuster D; Peters U; Boos J; Jürgens H; am Zehnhoff-Dinnesen A
Pharmacogenomics J; 2008 Feb; 8(1):23-8. PubMed ID: 17457342
[TBL] [Abstract][Full Text] [Related]
37. Cisplatin induced damage in kidney genomic DNA and nephrotoxicity in male rats: the protective effect of grape seed proanthocyanidin extract.
Saad AA; Youssef MI; El-Shennawy LK
Food Chem Toxicol; 2009 Jul; 47(7):1499-506. PubMed ID: 19351554
[TBL] [Abstract][Full Text] [Related]
38. A Systematic Review of Strategies to Prevent Cisplatin-Induced Nephrotoxicity.
Crona DJ; Faso A; Nishijima TF; McGraw KA; Galsky MD; Milowsky MI
Oncologist; 2017 May; 22(5):609-619. PubMed ID: 28438887
[TBL] [Abstract][Full Text] [Related]
39. Cisplatin nephrotoxicity affects magnesium and calcium metabolism.
Goren MP
Med Pediatr Oncol; 2003 Sep; 41(3):186-9. PubMed ID: 12868117
[TBL] [Abstract][Full Text] [Related]
40. Adjuvant electrochemotherapy for incompletely excised anal sac carcinoma in a dog.
Spugnini EP; Dotsinsky I; Mudrov N; Bufalini M; Giannini G; Citro G; Feroce F; Baldi A
In Vivo; 2008; 22(1):47-9. PubMed ID: 18396781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
